Northern Trust Corp Charles River Laboratories International, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 457,897 shares of CRL stock, worth $90.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

457,897

Previous 459,251 0.29%

Holding current value

$90.8 Million

Previous $124 Million 23.98%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $279,452 - $363,860	-1,354 Reduced 0.29%	457,897 $94.6 Million
Q1 2024 May 14, 2024	SELL	$203.52 - $273.43 $4.3 Million - $5.78 Million	-21,135 Reduced 4.4%	459,251 $124 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $2.81 Million - $4.08 Million	-17,081 Reduced 3.43%	480,386 $114 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $4.71 Million - $5.28 Million	24,249 Added 5.12%	497,467 $97.5 Million
Q2 2023 Aug 11, 2023	SELL	$183.71 - $210.25 $3.27 Million - $3.74 Million	-17,809 Reduced 3.63%	473,218 $99.5 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $1.01 Million - $1.37 Million	-5,272 Reduced 1.06%	491,027 $99.1 Million
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $339,817 - $431,120	1,724 Added 0.35%	496,299 $108 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $1 Million - $1.37 Million	-5,484 Reduced 1.1%	494,575 $97.3 Million
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $1.18 Million - $1.75 Million	-5,786 Reduced 1.14%	500,059 $107 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $2.98 Million - $4.22 Million	-11,644 Reduced 2.25%	505,845 $144 Million
Q4 2021 Feb 08, 2022	SELL	$351.38 - $448.68 $3.46 Million - $4.42 Million	-9,860 Reduced 1.87%	517,489 $195 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $5.36 Million - $6.59 Million	14,387 Added 2.8%	527,349 $218 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $22.3 Million - $28.1 Million	75,720 Added 17.32%	512,962 $190 Million
Q1 2021 May 12, 2021	BUY	$249.67 - $299.48 $10.1 Million - $12.1 Million	40,500 Added 10.21%	437,242 $127 Million
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $2.07 Million - $2.35 Million	-9,318 Reduced 2.29%	396,742 $99.1 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $3.17 Million - $4.09 Million	-18,041 Reduced 4.25%	406,060 $92 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $1.48 Million - $2.36 Million	12,444 Added 3.02%	424,101 $73.9 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $1.8 Million - $3.25 Million	18,226 Added 4.63%	411,657 $52 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $1.06 Million - $1.28 Million	8,372 Added 2.17%	393,431 $60.1 Million
Q3 2019 Nov 13, 2019	SELL	$125.07 - $143.67 $242,260 - $278,288	-1,937 Reduced 0.5%	385,059 $51 Million
Q2 2019 Aug 13, 2019	BUY	$123.4 - $148.55 $432,393 - $520,519	3,504 Added 0.91%	386,996 $54.9 Million
Q1 2019 May 13, 2019	BUY	$104.82 - $146.73 $1.11 Million - $1.55 Million	10,570 Added 2.83%	383,492 $55.7 Million
Q4 2018 Feb 12, 2019	BUY	$105.09 - $137.23 $335,552 - $438,175	3,193 Added 0.86%	372,922 $42.2 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $1.2 Million - $1.44 Million	-10,669 Reduced 2.8%	369,729 $49.7 Million
Q2 2018 Sep 18, 2018	SELL	$102.37 - $117.25 $298,510 - $341,901	-2,916 Reduced 0.76%	380,398 $42.7 Million
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $2.94 Million - $3.37 Million	-28,733 Reduced 6.97%	383,314 $43 Million
Q1 2018 May 09, 2018	SELL	$98.19 - $115.2 $1.14 Million - $1.34 Million	-11,600 Reduced 2.74%	412,047 $44 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $266,340 - $313,174	-2,652 Reduced 0.62%	423,647 $46.4 Million
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $41.2 Million - $46.6 Million	426,299	426,299 $46.1 Million

Others Institutions Holding CRL

# of Institutions

732

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Charles River Laboratories International, Inc. Transaction History